Contact this trialFirst, we need to learn more about you.
Topoisomerase I inhibitors
ELU001 for Ovarian and Endometrial Cancers
Recruiting1 awardPhase 1 & 2
Durham, North Carolina
This trial is testing ELU001, a new drug that targets advanced cancers by delivering cancer-fighting chemicals directly to the cancer cells. It focuses on adults with difficult-to-treat cancers that overproduce a specific protein and have no other treatment options. The drug acts like a guided missile, aiming to kill cancer cells while sparing healthy ones.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service